(Q24245736)

2

0 references

Mingming Zhang

3

0 references

Jun Xia

4

0 references

Xiehe Liu

5

0 references

Yanchun Yang

Cochrane Database of Systematic Reviews

6

0 references

publication date

19 October 2005

0 references

published in

0 references

cites work

A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

The effect of extract of ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

Effect of Warm-Supplementing Kidney Yang (WSKY) added to risperidone on quality of life in patients with schizophrenia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

Negative symptoms in schizophrenia. Definition and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

Issues in the meta-analysis of cluster randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

The relevance of herbal treatments for psychiatric practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

[Clinical study of shuizhi-dahuang mixture in treating schizophrenics with blood stasis syndrome]

21 January 2018

1 reference

12 December 2020

[Comparison between therapeutic effect of Risperidone in treating different traditional Chinese medicine syndrome types of first-episode schizophrenia]

1 reference

12 December 2020

Extract of Ginkgo biloba added to haloperidol was effective for positive symptoms in refractory schizophrenia

1 reference

12 December 2020

[Therapeutic effect of shuxuening combining neuroleptics for the treatment of chronic schizophrenia--a double blind study]

1 reference

12 December 2020

Treatment effects of traditional Chinese medicines Suoquan Pill and Wuling Powder on clozapine-induced hypersalivation in patients with schizophrenia: study protocol of a randomized, placebo-controlled trial.

1 reference

12 December 2020

[Current status of integrated traditional and Western medicine study on schizophrenia]

1 reference

12 December 2020

Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review

1 reference

12 December 2020

Traditional Chinese medical treatment to invigorate blood and relieve stasis treatment of schizophrenia: comparison with antipsychotics treatment

1 reference

12 December 2020

The effects of classic antipsychotic haloperidol plus the extract of ginkgo biloba on superoxide dismutase in patients with chronic refractory schizophrenia

1 reference

12 December 2020

Detecting skewness from summary information

1 reference

12 December 2020

Comparative study of schizophrenia treatment with electroacupuncture, herbs and chlorpromazine.

1 reference

12 December 2020

The Current Clinical Practice of Herbal Medicine in Psychiatry in Mainland China: A Review of Literature

1 reference

12 December 2020

[Preliminary investigation of risk stratification and prognosis of B-type brain natriuretic peptide in patients with sepsis]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003444.PUB2

7 January 2021